This inventor holds 5 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Uea Enterprises Limited, Progenika Biopharma S.a.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
5 out of 19 
1 out of 16 Years Active: 2022-2026
Title: Innovator Gemma Louise Kay: Pioneering Nucleic Acid Depletion Methods
Introduction
Gemma Louise Kay, located in Norwich, GB, is a remarkable inventor recognized for her contributions to the field of biotechnology. With a portfolio of 4 patents, she has made significant strides in developing methods for nucleic acid depletion, essential for biological research and diagnostics.
Latest Patents
Among her latest innovations are two patents focused on methods for depleting host nucleic acid in biological samples obtained from animal hosts. The first patent, titled "Method for Nucleic Acid Depletion," outlines a procedure that involves adding a cytolysin to the sample, followed by a process that physically depletes or renders the released nucleic acid unidentifiable. The second patent, "Mitochondrial Nucleic Acid Depletion and Detection," further expands on her research by detailing a method for depleting host mitochondrial DNA after host cells have been lysed. This invention also includes a related kit with reagents for executing the depletion method and provides a framework for isolating mitochondrial DNA effectively.
Career Highlights
Gemma has worked with reputable organizations, including UEA Enterprises Limited and Progenika Biopharma S.A., where she has honed her skills and expertise in biotechnology. Her innovative methods are paving the way for advancements in medical research, particularly in the analysis of nucleic acids.
Collaborations
Throughout her career, Gemma has collaborated with notable colleagues, including Justin Joseph O'Grady and John Richard Wain. These collaborations have enriched her work and contributed to her success in the field.
Conclusion
Gemma Louise Kay stands out as a leading inventor in the realm of biotechnology, particularly in nucleic acid research. Her inventive methods not only demonstrate her dedication but also illustrate the importance of innovation in advancing scientific understanding. With her ongoing contributions, Gemma continues to make a positive impact in her field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile